EA201270116A1 - Применение лекарственной формы для наружного нанесения, содержащей хитозан - Google Patents

Применение лекарственной формы для наружного нанесения, содержащей хитозан

Info

Publication number
EA201270116A1
EA201270116A1 EA201270116A EA201270116A EA201270116A1 EA 201270116 A1 EA201270116 A1 EA 201270116A1 EA 201270116 A EA201270116 A EA 201270116A EA 201270116 A EA201270116 A EA 201270116A EA 201270116 A1 EA201270116 A1 EA 201270116A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
nail
chitosan
containing chitosan
medical form
Prior art date
Application number
EA201270116A
Other languages
English (en)
Russian (ru)
Inventor
Федерико Маилланд
Original Assignee
Полихем С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38345983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201270116(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Полихем С.А. filed Critical Полихем С.А.
Publication of EA201270116A1 publication Critical patent/EA201270116A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
EA201270116A 2007-02-14 2008-02-07 Применение лекарственной формы для наружного нанесения, содержащей хитозан EA201270116A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07102335A EP1958638A1 (en) 2007-02-14 2007-02-14 Use of chitosans to increase nail growth rate

Publications (1)

Publication Number Publication Date
EA201270116A1 true EA201270116A1 (ru) 2012-06-29

Family

ID=38345983

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201270116A EA201270116A1 (ru) 2007-02-14 2008-02-07 Применение лекарственной формы для наружного нанесения, содержащей хитозан
EA200901093A EA018390B1 (ru) 2007-02-14 2008-02-07 Применение хитозана, аминополисахарида хитозана и/или его физиологически приемлемой соли для ускорения роста ногтей

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA200901093A EA018390B1 (ru) 2007-02-14 2008-02-07 Применение хитозана, аминополисахарида хитозана и/или его физиологически приемлемой соли для ускорения роста ногтей

Country Status (31)

Country Link
US (3) US8680074B2 (OSRAM)
EP (3) EP1958638A1 (OSRAM)
JP (3) JP5426401B2 (OSRAM)
KR (2) KR101323762B1 (OSRAM)
CN (2) CN102988405A (OSRAM)
AR (1) AR065316A1 (OSRAM)
AT (1) ATE522221T1 (OSRAM)
AU (1) AU2008214693B2 (OSRAM)
BR (1) BRPI0807595A2 (OSRAM)
CA (1) CA2677715C (OSRAM)
CL (2) CL2008000444A1 (OSRAM)
CO (1) CO6230979A2 (OSRAM)
CY (2) CY1112058T1 (OSRAM)
DK (2) DK2377541T3 (OSRAM)
EA (2) EA201270116A1 (OSRAM)
ES (2) ES2436647T3 (OSRAM)
HR (2) HRP20110667T1 (OSRAM)
IL (1) IL200269A (OSRAM)
MA (1) MA31236B1 (OSRAM)
ME (1) ME00830B (OSRAM)
MX (1) MX2009008686A (OSRAM)
MY (2) MY154499A (OSRAM)
NZ (1) NZ578896A (OSRAM)
PH (1) PH12014500274A1 (OSRAM)
PL (2) PL2117564T3 (OSRAM)
PT (2) PT2117564E (OSRAM)
RS (2) RS53143B (OSRAM)
SI (2) SI2377541T1 (OSRAM)
UA (1) UA100011C2 (OSRAM)
WO (1) WO2008098869A2 (OSRAM)
ZA (1) ZA200905443B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201490B2 (en) 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
WO2010109423A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroids cream comprising chitosan and a process to make it
CN103987370A (zh) * 2011-10-05 2014-08-13 阿勒根公司 用于增进指甲健康的组合物
WO2013093216A1 (fr) * 2011-12-20 2013-06-27 Laboratoires Urgo Composition topique filmogène et son utilisation pour traiter ou prévenir l'onychophagie
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2845597A1 (en) * 2013-09-10 2015-03-11 Polichem S.A. Hydroxypropyl chitosan for the treatment of onychomycosis
EP2910245A1 (en) * 2014-02-21 2015-08-26 Polichem SA Topical antifungal composition for treating onychomycosis
CN109893472A (zh) * 2019-04-09 2019-06-18 涿州皓原箔业有限公司 一种环保无毒水性卸甲液及其制备方法
ES2834732B2 (es) * 2019-12-17 2022-03-24 Univ Valladolid Solucion acuosa que comprende un complejo de inclusion, metodo de obtencion y su uso para aplicacion en cultivos y la mejora de su rendimiento
CN111388416B (zh) * 2020-02-26 2022-03-08 浙江康德药业集团股份有限公司 一种盐酸利多卡因胶浆剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3723811A1 (de) * 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
ES2101263T3 (es) 1993-02-19 1997-07-01 Howard Green Composiciones que contienen proteinas de corneocitos.
FR2718637A1 (fr) * 1994-04-15 1995-10-20 Oreal Composition cosmétique à appliquer sur l'ongle.
RU2108114C1 (ru) * 1996-12-27 1998-04-10 Товарищество с ограниченной ответственностью Научно-производственное предприятие "Эрлон", Лтд. Биологическая композиция для лечения ран "коллахит"
ITTO980264A1 (it) 1998-03-26 1999-09-26 Silvio Rossi Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
US6391334B1 (en) * 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
SI1455802T1 (sl) * 2001-12-14 2009-06-30 Dnp Canada Inc Uporaba hitozanskih oligosaharidov
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
EP1491202A1 (en) 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
JP3881992B2 (ja) 2004-07-30 2007-02-14 シャープ株式会社 受信装置、受信プログラム、および受信プログラムを記録した記録媒体
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
CN101663039B (zh) 2013-08-07
WO2008098869A2 (en) 2008-08-21
JP2015221823A (ja) 2015-12-10
JP6045663B2 (ja) 2016-12-14
WO2008098869A3 (en) 2008-10-09
JP5426401B2 (ja) 2014-02-26
PT2117564E (pt) 2011-10-17
KR101131015B1 (ko) 2012-03-29
MY163297A (en) 2017-09-15
EP1958638A1 (en) 2008-08-20
JP2010518138A (ja) 2010-05-27
US20100152133A1 (en) 2010-06-17
IL200269A (en) 2015-10-29
EA018390B1 (ru) 2013-07-30
EP2377541A1 (en) 2011-10-19
NZ578896A (en) 2012-02-24
CA2677715A1 (en) 2008-08-21
ES2369116T3 (es) 2011-11-25
PL2117564T3 (pl) 2012-03-30
ATE522221T1 (de) 2011-09-15
AU2008214693A2 (en) 2009-09-10
RS53143B (sr) 2014-06-30
AU2008214693B2 (en) 2013-05-02
PT2377541E (pt) 2013-11-21
SI2377541T1 (sl) 2014-01-31
KR20110075043A (ko) 2011-07-05
ES2436647T3 (es) 2014-01-03
CN102988405A (zh) 2013-03-27
CO6230979A2 (es) 2010-12-20
AU2008214693A1 (en) 2008-08-21
CA2677715C (en) 2014-10-14
US20140147401A1 (en) 2014-05-29
SI2117564T1 (sl) 2011-12-30
CN101663039A (zh) 2010-03-03
US20160015620A1 (en) 2016-01-21
DK2117564T3 (da) 2011-10-17
CL2013002052A1 (es) 2014-02-21
US8680074B2 (en) 2014-03-25
AR065316A1 (es) 2009-05-27
HRP20131175T1 (hr) 2014-01-17
US9173827B2 (en) 2015-11-03
CL2008000444A1 (es) 2008-08-22
EP2377541B1 (en) 2013-10-23
JP2013213048A (ja) 2013-10-17
KR101323762B1 (ko) 2013-11-01
IL200269A0 (en) 2010-04-29
MX2009008686A (es) 2009-08-21
HRP20110667T1 (hr) 2011-10-31
ZA200905443B (en) 2010-10-27
PH12014500274A1 (en) 2016-06-06
DK2377541T3 (da) 2013-11-11
RS52031B (sr) 2012-04-30
MA31236B1 (fr) 2010-03-01
CY1115136T1 (el) 2016-12-14
PL2377541T3 (pl) 2014-04-30
EP2117564B1 (en) 2011-08-31
MY154499A (en) 2015-06-30
ME00830B (me) 2012-03-20
HK1133189A1 (en) 2010-03-19
UA100011C2 (ru) 2012-11-12
KR20090121312A (ko) 2009-11-25
BRPI0807595A2 (pt) 2014-07-22
EA200901093A1 (ru) 2010-02-26
EP2117564A2 (en) 2009-11-18
CY1112058T1 (el) 2015-11-04

Similar Documents

Publication Publication Date Title
EA200901093A1 (ru) Способ ускорения роста ногтей, основанный на применении хитозана
MX2009013970A (es) Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos.
EP4663636A3 (en) Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
EA201390772A1 (ru) Новые соли и полиморфные формы афатиниба
DE602006018961D1 (de) KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZOL, ZUBEREITUNGSVERFAHREN DAFÜR UND DESSEN VERWENDUNG ZUR ARZNEIMITTELHERSTELLUNG
EA201001639A1 (ru) Композиции и способы их получения и применения
MX369385B (es) Productos para cicatrizar heridas tisulares.
MX338088B (es) Imidazoquinolinas y derivados de pirimidina como moduladores potentes de los procesos angiogenicos impulsados por el factor de crecimiento endotelial vascular (vegf).
WO2010071826A3 (en) Methods for treating osteoclast-related disease, compounds and compositions thereof
WO2010016683A3 (ko) 탈모의 예방, 치료, 또는 육모용 조성물
BR112014011981A2 (pt) formulações farmacêuticas
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
EA201291167A1 (ru) Замещенные гетероциклилбензилпиразолы и их применение
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
UA113749C2 (xx) Композиція для назального застосування з покращеною стабільністю
MX370065B (es) Acido (2r,4r)-5-(5'-cloro-2'-fluorobifenil-4-il)-2-hidroxi-4-[(5-m etiloxazol-2-carbonil)amino]pentanoico.
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
IN2014DN09240A (OSRAM)
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
WO2012004588A3 (en) Therapeutic agents 976
WO2010011599A3 (en) Pimethixene derivatives for promoting bone growth
WO2008130321A3 (en) Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain